Filing Details
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:TVRD
Tvardi Therapeutics, Inc. (TVRD) Files Quarterly Report for Q0
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Tvardi Therapeutics filed its quarterly report (Form 10-Q) on August 14, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.90 with a market capitalization of $42.1 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Tvardi Therapeutics, Inc.'s stock currently trades at $1.90 with a market capitalization of $42.1M.
The 10-Q provides Tvardi Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Tvardi Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TVRD Stock Page
Frequently Asked Questions
Where can I read TVRD's SEC filings?
Browse all filings on our TVRD SEC filings page.
What types of SEC filings does Tvardi Therapeutics, Inc. file?
Public companies like Tvardi Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.